Allogene Therapeutics
ALLO
#8751
Rank
A$0.32 B
Marketcap
A$0.95
Share price
-5.88%
Change (1 day)
-50.21%
Change (1 year)

EPS for Allogene Therapeutics (ALLO)

EPS in 2026 (TTM): A-$0.99

According to Allogene Therapeutics 's latest financial reports the company's current EPS (TTM) is A-$1.01. In 2025 the company made an earnings per share (EPS) of A-$1.31 an increase over its 2024 EPS that were of A-$2.01.

EPS history for Allogene Therapeutics from 2018 to 2026

Annual EPS

Year EPS Change
2026 (TTM)A-$0.99-24.73%
2025A-$1.31-34.59%
2024A-$2.01
2022A-$3.5122.75%
2021A-$2.86-9.13%
2020A-$3.1414.92%
2019A-$2.73-9.42%
2018A-$3.02

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
ORIC Pharmaceuticals
ORIC
A-$2.04 101.49%๐Ÿ‡บ๐Ÿ‡ธ USA